Podbregar Matej

7PUBLICATIONS

12CO-AUTHORS

Respiratory diseasesMedical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cellular immunologyCancer therapy (excl. chemotherapy and radiation therapy)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (7)

Sort by Publication Date:

|Jun 03, 2026

Individualized target heart rate in critically ill atrial fibrillation patients: insights from echocardiography and physiological signal analysis.

|Apr 23, 2025

Fulminant Red Yeast Rice-Associated Rhabdomyolysis with Acute Liver Injury and Hyperkalemia Treated with Extracorporeal Blood Purification Using CytoSorb.

Marko Kurnik, Tilen Markelj, Borut Žgavc

|Nov 16, 2024

Fatal rhabdomyolysis and fulminant myocarditis with malignant arrhythmias after one dose of ipilimumab and nivolumab.

Marko Kurnik, Petra Kolar Kus, Mihela Krepek

|Oct 26, 2024

Functional Magnetic Neuromuscular Stimulation vs. Routine Physiotherapy in the Critically Ill for Prevention of ICU Acquired Muscle Loss: A Randomised Controlled Trial.

Anej Skočir, Alja Jevšnik, Lidija Plaskan

|Jul 17, 2024

Tocilizumab and CytoSorb for delayed severe cytokine release syndrome after ipilimumab plus nivolumab immunotherapy.

Marko Kurnik, Fazarinc Peter, Podbregar Matej

|Jan 18, 2023

Pulmonary hypertension at admission predicts ICU mortality in elderly critically ill with severe COVID-19 pneumonia: retrospective cohort study.

Marko Kurnik, Helena Božič, Anže Vindišar

Pageof 2

Frequent Collaborators

Marko Kurnik

Jan Benes

Miłosz Jankowski

Konstanty Szułdrzynski

Mitja Lainscak

Zoltán Ruszkai

Krzysztof Kusza

Jakub Szrama

Peter Hegyi

Alan Sustic

Frequent Collaborators

Marko Kurnik

Jan Benes

Miłosz Jankowski

Konstanty Szułdrzynski